Oligometastatic Cancer – Views Beyond COMET

Saturday, March 12, 2022

10:10 AM – 11:10 AM US EST

Location: Las Olas IV, V, VI

Speaker(s)

Participants should be aware of the following financial/non-financial relationships:

Alexander Louie, MD, PhD, M.Sc., FRCPC: I do not have any relevant financial / non-financial relationships with any proprietary interests.

To discuss the current data supporting the use of SABR in oligometastastic cancer
To review practical considerations in reducing toxicity from SABR and oligometastatic cancer
To describe how to best integrate SABR in the context of novel an existing systemic agents